oral glp 1 agonist for type 2 diabetes New GLP-1 Guidelines in 2025 glp 1 antidiabetic πGLP-1 Drugs
Description
GLP-1 is a naturally occurring hormone produced in the gut and brain that regulates appetite, blood sugar, and satisfaction after eating
GIP receptor antagonists: Although agonism is currently dominant in approved therapies, antagonists are being explored in animal models for obesity, because blockade of GIP signalling may limit lipid storage and adiposity under certain conditions
While insurers receive rebates to offset some of their costs, the list prices of GLP-1 drugs are about $1,000 per month, and growing demand for these medications could put upward pressure on premiums

Obesity in and of itself is a legitimate, serious chronic disease, but people often confuse the accumulation of excess adipose tissue as a disease

2 GLP-1RA and SGLT2-I are two promising new classes of diabetes pharmacotherapy

Monitor for constipation and long-term fat-soluble vitamin (A, D, E, K) deficiency
